UPDATE 1-Documents show profit-seeking behind price hikes at Turing, Valeant
February 02, 2016 at 12:52 PM EST
WASHINGTON/NEW YORK, Feb 2 (Reuters) - A decision by Turing Pharmaceuticals to increase profits by raising the price of a lifesaving drug by 5,000 percent drove some patient co-pays up to $16,000, according to excerpts of documents that congressional committee members made public on Tuesday.